#R&D Services and Products
- Preclinical expertise
- Predictive models
- Companion tests
- New therapeutic targets
- Patient-derived tumor xenografts
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#R&D Services and Products
XenTech is an innovative biotech company specialized in the preclinical evaluation of cancer drugs and the identification of biomarkers and therapeutic targets.
XenTech was founded in 2006 by researchers from the Institut Curie having over 15 years of experience in preclinical pharmacology in oncology. This spin-off company dedicated to biomarker discovery and preclinical evaluation of anticancer therapies is known worldwide for its expertise in the field of patient-derived tumor xenografts (PDX).
Located on the Genopole Campus, its experimental models are housed at the CERFE.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
XenTech develops an innovative experimental platform based on one of the world’s largest collections of patient derived tumors xenografts (PDX). The collection is representative of the major types of cancer (breast, lung, colon, prostate) but also includes less common tumors (melanoma, ovarian cancer, renal cancer, pancreatic cancer, glioma, hepatoblastoma).
XenTech’s platform is of considerable value for translational research in oncology, notably for drug screening and the identification of biomarkers useful for precision oncology.
XenTech participates in the development of novel cancer therapies by offering its services, models and expertise in preclinical oncology to stakeholders in oncology research.
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
In same field
Quibiotic develops three molecular synthesis platforms aimed at innovatively modifying β-lactam rings for new anti-infectives.Discover
ADLIN Science is a mission-driven company that strives to transform the life sciences sector by providing solutions to bring together public actors (institutes, hospitals, universities) and private actors (biotechs, pharma). Our innovative approach is to develop the first decentralized Digital Research Environment (fundamental, translational, and clinical) dedicated to the entire public and private ecosystem. ADLIN is the scientific trusted third-party among all actors in the sector with the ambition to accelerate innovation in healthcare while participating in research financing.Discover
Altar / GinkGo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.Discover
Artificial intelligence to optimize and accelerate the development of gene therapiesDiscover
Manufacture and sale of new high performance transfecting agents for gene therapy, high-throughput screening and biomanufacturing. Cosmetic and therapeutic molecules from plant biomass.Discover
PhinC Development brings its expertise to small and mid-sized biotechs and pharmaceutical companies looking to advance their early-stage drug research.Discover
New England Biolabs is a private company manufacturing reagents for the life science industry particularly focused on products for genomic research.Discover
Hybrigenics Services proposes fee-for-services R&D support and provides innovative technological platforms for i) protein interaction studies (protein-protein, drug-protein, mechanisms of action) and ii) selection and validation of VHH antibodies.Discover
Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.Discover